Differential role of toll-interleukin 1 receptor domain-containing adaptor protein in toll-like receptor 2-mediated regulation of gene expression of hepatic cytokines and drug-metabolizing enzymes

Drug Metabolism and Disposition

Volumn 39, Issue 5, 2011, Pages 874-881

  Ghose, Romi ^a   Guo, Tao ^a   Vallejo, Jesus G ^b   Gandh, Adarsh ^a  

^a UNIVERSITY OF HOUSTON   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CELL NUCLEUS RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR; CYTOCHROME P450 2B10; CYTOCHROME P450 3A11; CYTOKINE; DRUG METABOLIZING ENZYME; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOTEICHOIC ACID; PREGNANE X RECEPTOR; RETINOID X RECEPTOR ALPHA; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; SULFOAMINOTRANSFERASE; TOLL INTERLEUKIN 1 RECEPTOR DOMAIN CONTAINING ADAPTOR PROTEIN; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG METABOLIZING ENZYME GENE; GENE; GENE EXPRESSION REGULATION; LIVER; LIVER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM;

ANIMALS; CELLS, CULTURED; CYTOCHROME P-450 ENZYME SYSTEM; CYTOKINES; DOWN-REGULATION; GENE EXPRESSION; HEPATOCYTES; LIPOPOLYSACCHARIDES; LIVER; MALE; MEMBRANE GLYCOPROTEINS; METABOLIC DETOXICATION, DRUG; METABOLIC DETOXICATION, PHASE I; METABOLIC DETOXICATION, PHASE II; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, INTERLEUKIN-1; SIGNAL TRANSDUCTION; TEICHOIC ACIDS; TOLL-LIKE RECEPTOR 2;

MUS; POSIBACTERIA;

EID: 79955048219     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.110.037382     Document Type: Article

References (41)

1. Akira S and Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4:499-511. (Pubitemid 38931765)
2. Ashino T, Oguro T, Shioda S, Horai R, Asano M, Sekikawa K, Iwakura Y, Numazawa S, and Yoshida T (2004) Involvement of interleukin-6 and tumor necrosis factor α in CYP3A11 and 2C29 down-regulation by bacillus Calmette-Guerin and lipopolysaccharide in mouse liver. Drug Metab Dispos 32:707-714. (Pubitemid 38821871)
3. Assenat E, Gerbal-Chaloin S, Larrey D, Saric J, Fabre JM, Maurel P, Vilarem MJ, and Pascussi JM (2004) Interleukin 1α inhibits CAR-induced expression of hepatic genes involved in drug and bilirubin clearance. Hepatology 40:951-960. (Pubitemid 39288129)
4. Berry MN and Friend DS (1969) High-yield preparation of isolated rat liver parenchymal cells: A biochemical and fine structural study. J Cell Biol 43:506-520.
5. Cheng PY, Wang M, and Morgan ET (2003) Rapid transcriptional suppression of rat cytochrome P450 genes by endotoxin treatment and its inhibition by curcumin. J Pharmacol Exp Ther 307:1205-1212. (Pubitemid 37494243)
6. Dunne A, Ejdeback M, Ludidi PL, O'Neill LA, and Gay NJ (2003) Structural complementarity of Toll/interleukin-1 receptor domains in Toll-like receptors and the adaptors Mal and MyD88. J Biol Chem 278:41443-41451. (Pubitemid 37280973)
7. Dunne A and O'Neill LA (2003) The interleukin-1 receptor/Toll-like receptor superfamily: Signal transduction during inflammation and host defense. Sci STKE 2003:re3.
8. Galloway E, Shin T, Huber N, Eismann T, Kuboki S, Schuster R, Blanchard J, Wong HR, and Lentsch AB (2008) Activation of hepatocytes by extracellular heat shock protein 72. Am J Physiol Cell Physiol 295:C514-C520. (Pubitemid 352755777)
9. Ghose R, Guo T, and Haque N (2009) Regulation of gene expression of hepatic drug metabolizing enzymes and transporters by the Toll-like receptor 2 ligand, lipoteichoic acid. Arch Biochem Biophys 481:123-130.
10. Ghose R, White D, Guo T, Vallejo J, and Karpen SJ (2008) Regulation of hepatic drugmetabolizing enzyme genes by Toll-like receptor 4 signaling is independent of Toll-interleukin 1 receptor domain-containing adaptor protein. Drug Metab Dispos 36:95-101.
11. Ghose R, Zimmerman TL, Thevananther S, and Karpen SJ (2004) Endotoxin leads to rapid subcellular re-localization of hepatic RXRα: A novel mechanism for reduced hepatic gene expression in inflammation. Nucl Recept 2:4.
12. Gu X, Ke S, Liu D, Sheng T, Thomas PE, Rabson AB, Gallo MA, Xie W, and Tian Y (2006) Role of NF-kB in regulation of PXR-mediated gene expression: A mechanism for the suppression of cytochrome P-450 3A4 by proinflammatory agents. J Biol Chem 281:17882-17889. (Pubitemid 44035587)
13. Hattor Y, Kasai K, Akimoto K, and Thiemermann C (1997) Induction of NO synthesis by lipoteichoic acid from Staphylococcus aureus in J774 macrophages: Involvement of a CD14- dependent pathway. Biochem Biophys Res Commun 233:375-379. (Pubitemid 27226633)
14. Horng T, Barton GM, Flavell RA, and Medzhitov R (2002) The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature 420:329-333. (Pubitemid 35398189)
15. Kagan JC and Medzhitov R (2006) Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling. Cell 125:943-955. (Pubitemid 43795199)
16. Ke S, Rabson AB, Germino JF, Gallo MA, and Tian Y (2001) Mechanism of suppression of cytochrome P-450 1A1 expression by tumor necrosis factor-α and lipopolysaccharide. J Biol Chem 276:39638-39644.
17. Kenny EF, Talbot S, Gong M, Golenbock DT, Bryant CE, and O'Neill LA (2009) MyD88 adaptor-like is not essential for TLR2 signaling and inhibits signaling by TLR3. J Immunol 183:3642-3651.
18. Li D, Zimmerman TL, Thevananther S, Lee HY, Kurie JM, and Karpen SJ (2002) Interleukin- 1β-mediated suppression of RXR:RAR transactivation of the Ntcp promoter is JNKdependent. J Biol Chem 277:31416-31422. (Pubitemid 34968941)
19. Liu S, Gallo DJ, Green AM, Williams DL, Gong X, Shapiro RA, Gambotto AA, Humphris EL, Vodovotz Y, and Billiar TR (2002) Role of Toll-like receptors in changes in gene expression and NF-kB activation in mouse hepatocytes stimulated with lipopolysaccharide. Infect Immun 70:3433-3442. (Pubitemid 34665980)
20. Martin GS, Mannino DM, Eaton S, and Moss M (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348:1546-1554. (Pubitemid 36437931)
21. Matsumura T, Degawa T, Takii T, Hayashi H, Okamoto T, Inoue J, and Onozaki K (2003) TRAF6-NF-kB pathway is essential for interleukin-1-induced TLR2 expression and its functional response to TLR2 ligand in murine hepatocytes. Immunology 109:127-136. (Pubitemid 36577983)
22. Morgan ET (2009) Impact of infectious and inflammatory disease on cytochrome P450-mediated drug metabolism and pharmacokinetics. Clin Pharmacol Ther 85:434-438.
23. Morgan ET, Goralski KB, Piquette-Miller M, Renton KW, Robertson GR, Chaluvadi MR, Charles KA, Clarke SJ, Kacevska M, Liddle C, et al. (2008) Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer. Drug Metab Dispos 36:205-216. (Pubitemid 351185732)
24. Oesch-Bartlomowicz B and Oesch F (2005) Phosphorylation of cytochromes P450: First discovery of a posttranslational modification of a drug-metabolizing enzyme. Biochem Biophys Res Commun 338:446-449. (Pubitemid 41540588)
25. Pagani R, Portolís MT, Bosch MA, Díaz-Laviada I, and Municio AM (1987) Direct and mediated Escherichia coli lipopolysaccharide action in primary hepatocyte cultures. Eur J Cell Biol 43:243-246.
26. Pascussi JM, Dvorák Z, Gerbal-Chaloin S, Assenat E, Maurel P, and Vilarem MJ (2003) Pathophysiological factors affecting CAR gene expression. Drug Metab Rev 35:255-268. (Pubitemid 38018105)
27. Rochette-Egly C (2003) Nuclear receptors: Integration of multiple signalling pathways through phosphorylation. Cell Signal 15:355-366. (Pubitemid 36254908)
28. Scott MJ and Billiar TR (2008) β2-Integrin-induced p38 MAPK activation is a key mediator in the CD14/TLR4/MD2-dependent uptake of lipopolysaccharide by hepatocytes. J Biol Chem 283:29433-29446.
29. Scott MJ, Liu S, Shapiro RA, Vodovotz Y, and Billiar TR (2009) Endotoxin uptake in mouse liver is blocked by endotoxin pretreatment through a suppressor of cytokine signaling-1- dependent mechanism. Hepatology 49:1695-1708.
30. Seki E and Brenner DA (2008) Toll-like receptors and adaptor molecules in liver disease: Update. Hepatology 48:322-335. (Pubitemid 351975556)
31. Sewer MB and Morgan ET (1997) Nitric oxide-independent suppression of P450 2C11 expression by interleukin-1β and endotoxin in primary rat hepatocytes. Biochem Pharmacol 54: 729-737. (Pubitemid 27404633)
32. Sheedy FJ and O'Neill LA (2007) The Troll in Toll: Mal and Tram as bridges for TLR2 and TLR4 signaling. J Leukoc Biol 82:196-203. (Pubitemid 47230627)
33. Su GL (2002) Lipopolysaccharides in liver injury: Molecular mechanisms of Kupffer cell activation. Am J Physiol Gastrointest Liver Physiol 283:G256-G265. (Pubitemid 34791290)
34. Takeuchi O and Akira S (2010) Pattern recognition receptors and inflammation. Cell 140:805-820.
35. Warren GW, Poloyac SM, Gary DS, Mattson MP, and Blouin RA (1999) Hepatic cytochrome P-450 expression in tumor necrosis factor-α receptor (p55/p75) knockout mice after endotoxin administration. J Pharmacol Exp Ther 288:945-950. (Pubitemid 29254130)
36. Warren GW, van Ess PJ, Watson AM, Mattson MP, and Blouin RA (2001) Cytochrome P450 and antioxidant activity in interleukin-6 knockout mice after induction of the acute-phase response. J Interferon Cytokine Res 21:821-826. (Pubitemid 33078520)
37. Xie W (2009) Nuclear Receptors in Drug Metabolism, John Wiley & Sons, Hoboken, NJ.
38. Xu DX, Wei W, Sun MF, Wu CY, Wang JP, Wei LZ, and Zhou CF (2004) Kupffer cells and reactive oxygen species partially mediate lipopolysaccharide-induced downregulation of nuclear receptor pregnane X receptor and its target gene CYP3a in mouse liver. Free Radic Biol Med 37:10-22. (Pubitemid 38746647)
39. Yu R, Lei W, Mandlekar S, Weber MJ, Der CJ, Wu J, and Kong AN (1999) Role of a mitogen-activated protein kinase pathway in the induction of phase II detoxifying enzymes by chemicals. J Biol Chem 274:27545-27552.
40. Zhou C, Tabb MM, Nelson EL, Grün F, Verma S, Sadatrafiei A, Lin M, Mallick S, Forman BM, Thummel KE, et al. (2006) Mutual repression between steroid and xenobiotic receptor and NF-kB signaling pathways links xenobiotic metabolism and inflammation. J Clin Invest 116:2280-2289. (Pubitemid 44162338)
41. Zimmerman TL, Thevananther S, Ghose R, Burns AR, and Karpen SJ (2006) Nuclear export of retinoid X receptor α in response to interleukin-1β-mediated cell signaling: Roles for JNK and SER260. J Biol Chem 281:15434-15440. (Pubitemid 43855135)